首页 > 最新文献

Current Ophthalmology Reports最新文献

英文 中文
A systematic review of acute zonal occult outer retinopathy with a focus on attempted treatment modalities. 对急性区域性隐匿性外视网膜病变的系统回顾,重点是尝试治疗方式。
IF 0.9 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1007/s40135-022-00305-4
Benjamin R Lin, Jonathan F Russell, Hasenin Al-Khersan, Raquel Goldhardt
{"title":"A systematic review of acute zonal occult outer retinopathy with a focus on attempted treatment modalities.","authors":"Benjamin R Lin, Jonathan F Russell, Hasenin Al-Khersan, Raquel Goldhardt","doi":"10.1007/s40135-022-00305-4","DOIUrl":"10.1007/s40135-022-00305-4","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894323/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9236774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Outcomes of Pythium keratitis: a meta-analysis of individual patient data. 角膜炎的预后:个体患者数据的荟萃分析。
IF 0.9 Q2 Medicine Pub Date : 2022-12-01 Epub Date: 2022-11-10 DOI: 10.1007/s40135-022-00302-7
Binh Cao, Vishnu Teja Gonugunta, Naveen Radhakrishnan, Prajna Lalitha, Bharat Gurnani, Kirandeep Kaur, Geetha Iyer, Shweta Agarwal, Bhaskar Srinivasan, Jeremy D Keenan, N Venkatesh Prajna

Background: Pythium keratitis is a difficult-to-treat corneal infection.

Methods: A meta-analysis of individual patient data from observational studies of Pythium keratitis was performed. The outcomes of interest were therapeutic penetrating keratoplasty (TPK) and globe removal (evisceration, enucleation, or exenteration); the main exposures were linezolid and azithromycin use.

Findings: Of 46 eligible articles, individual patient data were available for 306 eyes (34 studies). Pythium keratitis was associated with high rates of TPK (80%, 95%CI 70-87%) and globe removal (25%, 95%CI 13-43). In multivariable models adjusting for age and country, fewer TPKs were performed in patients treated with azithromycin (RR=0.80, 95%CI 0.67-0.96; P=0.04) and linezolid (RR=0.82, 95%CI 0.67-0.99; P=0.02).

Conclusions: Studies of Pythium keratitis reported high rates of TPK and globe removal. Use of azithromycin and linezolid was associated with a lower rate of TPK. While promising, these results should be interpreted with caution given the biases inherent to observational studies.

背景:角膜炎是一种难治性角膜感染。方法:对来自角膜炎观察性研究的个体患者数据进行荟萃分析。关注的结果是治疗性穿透性角膜移植术(TPK)和眼球摘除(剜出、去核或剜出);主要暴露是利奈唑胺和阿奇霉素的使用。结果:在46篇符合条件的文章中,可获得306只眼睛(34项研究)的个体患者数据。角膜炎与高TPK率(80%,95%CI 70-87%)和球清除率(25%,95%CI 13-43)相关。在调整年龄和国家的多变量模型中,接受阿奇霉素治疗的患者较少进行TPKs (RR=0.80, 95%CI 0.67-0.96;P=0.04)和利奈唑胺(RR=0.82, 95%CI 0.67-0.99;P = 0.02)。结论:对角膜炎的研究报告了较高的TPK和球体去除率。使用阿奇霉素和利奈唑胺与较低的TPK率相关。虽然有希望,但考虑到观察性研究固有的偏差,这些结果应该谨慎解释。
{"title":"Outcomes of Pythium keratitis: a meta-analysis of individual patient data.","authors":"Binh Cao, Vishnu Teja Gonugunta, Naveen Radhakrishnan, Prajna Lalitha, Bharat Gurnani, Kirandeep Kaur, Geetha Iyer, Shweta Agarwal, Bhaskar Srinivasan, Jeremy D Keenan, N Venkatesh Prajna","doi":"10.1007/s40135-022-00302-7","DOIUrl":"10.1007/s40135-022-00302-7","url":null,"abstract":"<p><strong>Background: </strong>Pythium keratitis is a difficult-to-treat corneal infection.</p><p><strong>Methods: </strong>A meta-analysis of individual patient data from observational studies of Pythium keratitis was performed. The outcomes of interest were therapeutic penetrating keratoplasty (TPK) and globe removal (evisceration, enucleation, or exenteration); the main exposures were linezolid and azithromycin use.</p><p><strong>Findings: </strong>Of 46 eligible articles, individual patient data were available for 306 eyes (34 studies). Pythium keratitis was associated with high rates of TPK (80%, 95%CI 70-87%) and globe removal (25%, 95%CI 13-43). In multivariable models adjusting for age and country, fewer TPKs were performed in patients treated with azithromycin (RR=0.80, 95%CI 0.67-0.96; <i>P</i>=0.04) and linezolid (RR=0.82, 95%CI 0.67-0.99; <i>P</i>=0.02).</p><p><strong>Conclusions: </strong>Studies of Pythium keratitis reported high rates of TPK and globe removal. Use of azithromycin and linezolid was associated with a lower rate of TPK. While promising, these results should be interpreted with caution given the biases inherent to observational studies.</p>","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9553049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ocular Surface Ion Transport and Dry Eye Disease. 眼表面离子迁移与干眼症
IF 0.9 Q2 Medicine Pub Date : 2022-12-01 Epub Date: 2022-10-20 DOI: 10.1007/s40135-022-00295-3
Ethan S Lindgren, Onur Cil, Alan S Verkman, Neel D Pasricha

Purpose of review: To review the role of ocular surface epithelial (corneal and conjunctival) ion transporters in the pathogenesis and treatment of dry eye disease (DED).

Recent findings: Currently, anti-inflammatory agents are the mainstay of DED treatment, though there are several agents in development that target ion transport proteins on the ocular surface, acting by pro-secretory or anti-absorptive mechanisms to increase the tear fluid Film volume. Activation or inhibition of selected ion transporters can alter tear fluid osmolality, driving water transport onto the ocular surface via osmosis. Several ion transporters have been proposed as potential therapeutic targets for DED, including the cystic fibrosis transmembrane conductance regulator (CFTR), calcium-activated chloride channels (CaCCs), and the epithelial sodium channel (ENaC).

Summary: Ocular surface epithelial cell ion transporters are promising targets for pro-secretory and anti-absorptive therapies of DED.

综述目的:回顾眼表上皮(角膜和结膜)离子转运体在干眼症(DED)发病机制和治疗中的作用:目前,抗炎药物是治疗干眼症的主要药物,但也有几种药物正在研发中,这些药物以眼表面的离子转运蛋白为靶点,通过促进分泌或抗吸收机制增加泪液膜容量。激活或抑制特定的离子转运体可改变泪液渗透压,通过渗透作用将水分转运到眼表。摘要:眼表上皮细胞离子转运体是促进分泌和抗吸收治疗 DED 的潜在靶点。
{"title":"Ocular Surface Ion Transport and Dry Eye Disease.","authors":"Ethan S Lindgren, Onur Cil, Alan S Verkman, Neel D Pasricha","doi":"10.1007/s40135-022-00295-3","DOIUrl":"10.1007/s40135-022-00295-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>To review the role of ocular surface epithelial (corneal and conjunctival) ion transporters in the pathogenesis and treatment of dry eye disease (DED).</p><p><strong>Recent findings: </strong>Currently, anti-inflammatory agents are the mainstay of DED treatment, though there are several agents in development that target ion transport proteins on the ocular surface, acting by pro-secretory or anti-absorptive mechanisms to increase the tear fluid Film volume. Activation or inhibition of selected ion transporters can alter tear fluid osmolality, driving water transport onto the ocular surface via osmosis. Several ion transporters have been proposed as potential therapeutic targets for DED, including the cystic fibrosis transmembrane conductance regulator (CFTR), calcium-activated chloride channels (CaCCs), and the epithelial sodium channel (ENaC).</p><p><strong>Summary: </strong>Ocular surface epithelial cell ion transporters are promising targets for pro-secretory and anti-absorptive therapies of DED.</p>","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10783585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49646151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on the Light-Adjustable Lens (LAL) 可调光镜头(LAL)的最新进展
IF 0.9 Q2 Medicine Pub Date : 2022-11-28 DOI: 10.1007/s40135-022-00306-3
Gabriel A Quesada, K. Waltz, Rodrigo A Quesada, León Colindres, Eduardo Alas, Amarilis Portillo, Rafael Perez-Varela, Pablo Ortiz
{"title":"Update on the Light-Adjustable Lens (LAL)","authors":"Gabriel A Quesada, K. Waltz, Rodrigo A Quesada, León Colindres, Eduardo Alas, Amarilis Portillo, Rafael Perez-Varela, Pablo Ortiz","doi":"10.1007/s40135-022-00306-3","DOIUrl":"https://doi.org/10.1007/s40135-022-00306-3","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47476708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Radiation Cataract Management: Outcomes in Individuals with Uveal Melanoma 放射后白内障治疗:葡萄膜黑色素瘤患者的疗效
IF 0.9 Q2 Medicine Pub Date : 2022-11-25 DOI: 10.1007/s40135-022-00304-5
Paula A. Sepulveda-Beltran, H. Levine, A. Gibbons, A. Maharaj, Daniel S Choi, Jaime D. Martinez, Z. Corrêa, G. Amescua, J. Harbour
{"title":"Post-Radiation Cataract Management: Outcomes in Individuals with Uveal Melanoma","authors":"Paula A. Sepulveda-Beltran, H. Levine, A. Gibbons, A. Maharaj, Daniel S Choi, Jaime D. Martinez, Z. Corrêa, G. Amescua, J. Harbour","doi":"10.1007/s40135-022-00304-5","DOIUrl":"https://doi.org/10.1007/s40135-022-00304-5","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43031406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demodex Blepharitis: Its Role and Treatment in Ocular Surface Disease 蠕形螨性睑炎:在眼表疾病中的作用及治疗
IF 0.9 Q2 Medicine Pub Date : 2022-11-11 DOI: 10.1007/s40135-022-00300-9
Nicole Duncan, Priyanka Sood, Sumitra S. Khandelwal
{"title":"Demodex Blepharitis: Its Role and Treatment in Ocular Surface Disease","authors":"Nicole Duncan, Priyanka Sood, Sumitra S. Khandelwal","doi":"10.1007/s40135-022-00300-9","DOIUrl":"https://doi.org/10.1007/s40135-022-00300-9","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47177528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Potential of Stem Cells as Treatment for Ocular Surface Diseases 干细胞治疗眼表疾病的潜力
IF 0.9 Q2 Medicine Pub Date : 2022-11-11 DOI: 10.1007/s40135-022-00303-6
A. Serrano, K. Osei, Marcela Huertas-Bello, Alfonso L. Sabater
{"title":"The Potential of Stem Cells as Treatment for Ocular Surface Diseases","authors":"A. Serrano, K. Osei, Marcela Huertas-Bello, Alfonso L. Sabater","doi":"10.1007/s40135-022-00303-6","DOIUrl":"https://doi.org/10.1007/s40135-022-00303-6","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52779269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral Ulcerative Keratitis: Management 外周溃疡性角膜炎的治疗
IF 0.9 Q2 Medicine Pub Date : 2022-11-09 DOI: 10.1007/s40135-022-00301-8
Amol A. Sura
{"title":"Peripheral Ulcerative Keratitis: Management","authors":"Amol A. Sura","doi":"10.1007/s40135-022-00301-8","DOIUrl":"https://doi.org/10.1007/s40135-022-00301-8","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44276201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intense Pulse Light Therapy for Meibomian Gland Dysfunction 强脉冲光治疗睑板腺功能障碍
IF 0.9 Q2 Medicine Pub Date : 2022-11-07 DOI: 10.1007/s40135-022-00297-1
Jeremy J. Kudrna, Clever Nguyen, Gargi K. Vora
{"title":"Intense Pulse Light Therapy for Meibomian Gland Dysfunction","authors":"Jeremy J. Kudrna, Clever Nguyen, Gargi K. Vora","doi":"10.1007/s40135-022-00297-1","DOIUrl":"https://doi.org/10.1007/s40135-022-00297-1","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44463435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on the Management of Acanthamoeba Keratitis 棘阿米巴角膜炎管理的最新进展
IF 0.9 Q2 Medicine Pub Date : 2022-11-05 DOI: 10.1007/s40135-022-00296-2
Colton McCoy, Shaivi Patel, P. Thulasi
{"title":"Update on the Management of Acanthamoeba Keratitis","authors":"Colton McCoy, Shaivi Patel, P. Thulasi","doi":"10.1007/s40135-022-00296-2","DOIUrl":"https://doi.org/10.1007/s40135-022-00296-2","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42541686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Current Ophthalmology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1